Global /China /Healthcare /Medical Distribution /301126

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

301126

• SHE: 301126 • Delayed

11.74CNY 0.4%

1.73 USD

As of 10 June 2026, Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd has a market cap of $356.03M USD, ranking #17468 globally and #5427 in China. It ranks #1585 in the Healthcare sector, and #54 in the Medical Distribution industry.

Global Rank

17468

Country Rank

5427

Sector Rank

1585

Industry Rank

Key Stats

Market Cap

$356.03MUSD

2.41B CNY

Enterprise Value

$835.05MUSD

5.66B CNY

Revenue (TTM)

$771.96MUSD

5.23B CNY

EBITDA (TTM)

$22.18MUSD

150.26M CNY

Net Income (TTM)

-$35.38MUSD

-239.64M CNY

EBITDA Margin

2.9%

Profit Margin

-4.6%

PS Ratio

0.5

PB Ratio

1.5

EV/EBITDA

34.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Distribution

CEO

Shengli Hu open_in_new

Employees

4,887

Founded

2002

Website

djwk.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.4%	4.4%	3.4%	-3.9%	-3.5%	-4.5%	19%	-18%	-63%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	301126 湖南达嘉维康医药产业股份有限公司 Class A ISIN: CNE1000054V3 Shares Out.: Shares Outstanding: 205.403M¹ TV: TradingView: SZSE: 301126 SA: Stock Analysis: SHE: 301126 YF: Yahoo Finance: 301126.SZ GF: Google Finance: SHE: 301126 BA: Barron's: 301126 MS: Morningstar: XSHE: 301126	11.74 CNY	TV: TradingView: SZSE: 301126 SA: Stock Analysis: SHE: 301126 YF: Yahoo Finance: 301126.SZ GF: Google Finance: SHE: 301126 BA: Barron's: 301126 MS: Morningstar: XSHE: 301126

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. It provides raw materials, biological products, chemical drugs, Chinese herbal medicines, medical devices, and other products. The company also offers Chinese patent medicines in the form of granules, capsules, particles, tablets, slices, and pills; foods, such as beverages, drinks, and probiotic beverages; and cleansing and care products. In addition, it provides pharmaceutical logistics services; and operates reproductive hospitals. The company was formerly known as Hunan Tongjian Pharmacy CO., LTD and changed its name to Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd in August 2016. Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd was founded in 2002 and is headquartered in Changsha, China.

Similar Companies

Industry: Medical Distribution (China)

Name	Market Cap (USD) diff.	PE	Country
Sinopharm Group Co. Ltd. SHEK: 1099	$7.48B 58.61B HKD 2K%	7.2	China
Jointown Pharmaceutical Group Co., Ltd. SSE: 600998	$3.82B 25.88B CNY 973%	13.3	China
Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. SHE: 301584	$1.63B 11.06B CNY 359%	31.2	China
Shinva Medical Instrument Co.,Ltd. SSE: 600587	$1.23B 8.31B CNY 245%	17.9	China
Shanghai Haohai Biological Technology Co., Ltd. SSE: 688366	$1.22B 8.24B CNY 242%	35.2	China
Nanjing Pharmaceutical Group Company Ltd. SSE: 600713	$1.05B 7.12B CNY 195%	12.8	China

Industry: Medical Distribution (Global)

Name	Market Cap (USD) diff.	PE	Country
McKesson Corp. NYSE: MCK	$100.76B 28K%	24.0	United States
Cencora, Inc. NYSE: COR	$60.58B 17K%	37.4	United States
Cardinal Health, Inc. NYSE: CAH	$47.73B 13K%	29.6	United States
Henry Schein, Inc. NASDAQ: HSIC	$8.47B 2K%	22.6	United States
Galenica AG SIX: GALE	$5.27B 4.2B CHF 1K%	23.0	Switzerland
DKSH Holding AG SIX: DKSH	$4.8B 3.83B CHF 1K%	18.9	Switzerland

chevron_leftBack